Latest Breaking News On - Biocardia inc - Page 5 : comparemela.com

BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study

BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesPeter altmanMiranda petoDavid mcclungCenters for medicare medicaid servicesBiocardia incExchange commission onCardiamp cell therapy programMaryland stem cell research fundHeart failureMedicaid servicesNew technologyAmbulatory payment classificationsFailure trialHeart failure therapeuticsChief executive

BioCardia, Inc (NASDAQ:BCDA) CEO Buys $49,729 68 in Stock

BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) CEO Peter Altman acquired 108,108 shares of the stock in a transaction that occurred on Tuesday, February 13th. The shares were acquired at an average cost of $0.46 per share, with a total value of $49,729.68. Following the transaction, the chief executive officer now owns 555,447 shares in […]

Peter altmanCm managementBiocardia incBiocardia company profileBlackrock incDimensional fund advisorsRenaissance technologiesSecurities exchange commissionMillennium managementGet free reportExchange commissionFund advisorsBiocardia dailyNasdaq bcdaInsider tradingNsider trades

BioCardia, Inc (NASDAQ:BCDA) Sees Large Decline in Short Interest

BioCardia, Inc (NASDAQ:BCDA) Sees Large Decline in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Vontobel holding ltdRenaissance technologiesBlackrock incDimensional fund advisorsMillennium managementBiocardia incGet free reportPhillip md et al frostFund advisorsBiocardia daily

Phillip Md Et Al Frost Sells 129,802 Shares of BioCardia, Inc (NASDAQ:BCDA) Stock

BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) major shareholder Phillip Md Et Al Frost sold 129,802 shares of BioCardia stock in a transaction on Friday, January 19th. The stock was sold at an average price of $0.43, for a total transaction of $55,814.86. Following the completion of the transaction, the insider now owns 1,896,025 shares […]

Biocardia incDimensional fund advisorsMillennium managementVontobel holding ltdBlackrock incBiocardia company profileRenaissance technologiesGet free reportPhillip md et al frostFund advisorsBiocardia dailyNasdaq bcdaInsider tradingNsider trades

Insider Selling: BioCardia, Inc (NASDAQ:BCDA) Major Shareholder Sells $55,814 86 in Stock

BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) major shareholder Phillip Md Et Al Frost sold 129,802 shares of BioCardia stock in a transaction that occurred on Friday, January 19th. The stock was sold at an average price of $0.43, for a total value of $55,814.86. Following the transaction, the insider now owns 1,896,025 shares of […]

Biocardia incRenaissance technologiesBiocardia company profileMillennium managementVontobel holding ltdDimensional fund advisorsBlackrock incGet free reportPhillip md et al frostFund advisorsBiocardia dailyNasdaq bcdaInsider tradingNsider trades